4//SEC Filing
GARDINER SANDRA A. 4
Accession 0000899243-22-008015
CIK 0001625101other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 1:42 PM ET
Size
6.2 KB
Accession
0000899243-22-008015
Insider Transaction Report
Form 4
GARDINER SANDRA
CFO & EVP Admin. and Finance
Transactions
- Award
Stock Option (right to buy)
2021-12-14+25,961→ 51,922 totalExercise: $13.94From: 2021-12-14Exp: 2029-11-18→ Common Stock (25,961 underlying)
Footnotes (2)
- [F1]On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares.
- [F2]Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001218574
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 1:42 PM ET
- Size
- 6.2 KB